阿格马丁可以改善肝功能,平衡性能和神经元损伤,在由胆管结合诱导的肝脑病症中
Sepideh Ganjalikhan-Hakemi1, Majid Asadi-Shekaari2, Fahimeh Pourjafari1
1Student Research Committee, Department of Anatomical Sciences, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Brain and behavior
|June 20, 2023
概括
在肝脏脑病变 (HE) 的动物模型中,阿格马丁 (AGM) 的使用减少了运动缺陷和肝损伤. 这表明了agmatine的存在.
科学领域:
- 神经科学是一个神经科学.
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝脑病 (HE) 是肝脏疾病的一种严重并发症.
- 运动和认知缺陷是HE的关键特征.
- 胆道绑定 (BDL) 是诱导动物中HE的一个常见模型.
研究的目的:
- 在BDL诱导的HE大鼠模型中研究阿格马丁 (AGM) 的神经保护作用.
- 评估AGM对运动功能,认知缺陷和神经元损伤的影响.
主要方法:
- 威斯塔尔老鼠接受了BDL手术,并接受了AGM (40或80毫克/公斤) 的治疗.
- 通过开放场地,旋转杆和电线握力测试来评估运动功能.
- 用新型物体识别测试 (NOR) 评估认知功能.
- 在血清和大脑组织 (海马和小脑) 中分析了肝脏标志物,亡和神经元损伤.
主要成果:
- BDL显著损害了肝功能,并导致神经元损伤和脑中的亡.
- AGM治疗改善了肝酶升高,运动缺陷和大脑神经元损伤.
- AGM部分降低了亡,并没有影响NOR的性能.
结论:
- 阿格马丁 (AGM) 在肝脏脑病变 (HE) 的大鼠模型中显示出神经保护性质.
- AGM可能是HE的潜在治疗剂,可能通过直接影响肝功能和神经保护.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
165
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
165
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
721
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
721
Anticholinesterase Agents: Poisoning and Treatment
926
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
926
Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223
Direct-Acting Cholinergic Agonists: Therapeutic Uses
797
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
797


